Literature DB >> 15090264

The development of larger cells that spontaneously escape senescence--a step during the immortalization of a human cancer cell line.

Carmen C Diaconu1, Coralia Bleotu, Mihaela Chivu, Irina Alexiu, Daniela Petrusca, Gabriela Anton, Ruxandra Achim, Simona M Ruta, C Cernescu.   

Abstract

There are few information concerning the changes associated with the transition interval when slow growing, primary explanted human cancer cells are displaced by new selected faster growing cells and became an immortal cell line. In a previous paper (J. Cell. Mol. Med., 5: 49-59, 2001) we described the TV cell line derived from a laryngeal tumor which harbors human papillomavirus (HPV) gene sequences throughout more than sixty in vitro passages. In this paper we analyze the modifications observed during the crisis interval when significant amount of cells senesce but occasional cells acquire some mutations that make them immortal. Confocal microscopy analysis revealed the heterogeneity of the cells in terms of their size and nucleus/cell ratio. Proliferation capacity was assessed by flow cytometry analyzing DNA content and expression of transferrin receptor (CD71). We discussed the possibility that HPV genome sequences alleviate a proliferation block during the crisis growth arrest of human larynx carcinoma cell line and the possibility that the cells monitor their size and growth by measuring the levels of some protein whose synthesis is coupled to cell development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090264      PMCID: PMC6740141          DOI: 10.1111/j.1582-4934.2004.tb00263.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  1 in total

1.  Antimicrobial activity of some new thioureides derived from 2-(4-chlorophenoxymethyl)benzoic acid.

Authors:  Carmen Limban; Mariana-Carmen Balotescu Chifiriuc; Alexandru-Vasile Missir; Ileana Cornelia Chiriţă; Coralia Bleotu
Journal:  Molecules       Date:  2008-03-04       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.